SOURCE: American Scientific Resources

June 11, 2008 15:55 ET

American Scientific Resources Clarifies Capital Structure, Disclosure

WESTON, FL--(Marketwire - June 11, 2008) - American Scientific Resources, Inc. (PINKSHEETS: ASFX) today announced that it wished to clarify any confusion that may exist in the marketplace as to its capital structure. It had come to the attention of the Company that an inadvertent miscommunication on the part of the Company's transfer agent had caused confusion to some of the ASFX's shareholders. The Company's advisory team has determined it necessary to update the investment community as to the correct share structure of the Company.

Dr. Christopher F. Tirotta, CEO of American Scientific Resources, Inc., states, "Due to incorrect information which may have been given to its shareholders by the transfer agent, the Company would like to confirm that it is authorized to issue 250,000,000 shares of common stock. There are 139,238,026 shares issued and outstanding and 17,958,571 in the float as of June 6, 2008."

The company further wishes to assure investors that steps were taken with the transfer agent and the Company to assure that such miscommunications do not occur again in the future.

In an interview conducted by on April 15th, "Doctor & CEO of Health and Safety Products Company Discusses Corporate Wellbeing," Dr. Tirotta provided his unique perspective on the Company's history and development as well as a broad overview of the Company's objectives. The exclusive interview is available only at

The Company recently announced record sales for Q1 2008 and disclosed 4 previous years of audited financials.

About American Scientific Resources, Inc.

American Scientific Resources, Inc. is a leading provider of innovative next-generation, health, medical, and safety products distributed primarily through nationwide medical suppliers, infomercials and on-line sites. Additional information about ASFX may be found at

Safe Harbor

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

Contact Information

  • Contact:
    Ronald Garner
    Investor Hotline: